Cancer spread to Jimmy Carter's brain 9 years ago. Here's how he's lived so long.
A new approach to cancer treatment became available shortly before Jimmy Carter needed it. Now it's a pillar of care.
2minutemedicine.com3h
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
The 5-year OS rate for pembrolizumab vs placebo was 86.1% vs 81.7% with HR 0.51 (significant). 2. Immune-mediated adverse ...
Pharmaceutical Technology3h
Keytruda and Opdivo: a decade review
PD-1 inhibitors have revolutionised cancer treatment over the last decade, with their success attributed to Keytruda and ...
Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length ...
Medscape7h
FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy
After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...